http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6719425

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 535
issn 0031-3998
1530-0447
issueIdentifier 3
pageRange 527-535
publicationName Pediatric Research
startingPage 527
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d8d749c8f8114259a5a433a67add605d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bf8fd404907a5002a52fabb450e6fe8b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1a7115803d3a23740457918a672348a3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_60c506260d4967bf259f1d2931c17747
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5f9487b5d735dcaa9605c55de93956d9
bibliographicCitation Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatric Research. 2017 May 31;82(3):527–35. doi: 10.1038/pr.2017.74.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9358ff0c8515e627d132ed4992fe8d8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aabce0370daeb5121cf1496d754374cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b127662126b4fea974896d53ff080af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d419a0f2aa6b128c17f8b954b0e14ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6395c46d49809b654f0ec62d74b3e7bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd4c8b812c019f3143138fd22f7dc45b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3b7422b7723487dc6412609de84ec99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76f816080890ebe4c8d0ec3629dd2dce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbaf4f48566bbdb5424b3a6522e46684
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b9813681e8d76d182b6b06a0839134c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5d8dec5d682a131f00cf96ed0c4492b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce9cf8c80f5fb67b2840c5ceaf9f8019
date 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/28419087
https://pubmed.ncbi.nlm.nih.gov/PMC5766270
https://doi.org/10.1038/pr.2017.74
isPartOf https://portal.issn.org/resource/ISSN/1530-0447
https://portal.issn.org/resource/ISSN/0031-3998
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6400
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA
discusses http://id.nlm.nih.gov/mesh/M0539021
http://id.nlm.nih.gov/mesh/M0406100
http://id.nlm.nih.gov/mesh/M0018809
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_04394a0e58b99b65611235b6de1a9206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518696

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83463
http://rdf.ncbi.nlm.nih.gov/pubchem/conserveddomain/PSSMID381502

Total number of triples: 64.